*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>(2R,3S)-4-(2-Quinoxalinyl)-1,2,3-butanetriol is a chiral intermediate synthesized via asymmetric hydrogenation or resolution. The <strong>molecular formula</strong> is C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>, with <strong>CAS No. 65097-89-0</strong>. It serves as a critical scaffold for pharmaceutical manufacturing.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceuticals:</strong> Precursor for HIV protease inhibitors and antiretroviral therapies.</li>
<li><strong>Research:</strong> Used in stereoselective synthesis studies and medicinal chemistry libraries.</li>
<li><strong>Agrochemicals:</strong> Potential building block for novel fungicides and herbicides.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at controlled temperatures below -20°C to prevent racemization. Handle with appropriate PPE; avoid inhalation or skin contact due to potential irritancy. Strictly regulated for clinical use only.</p>